One day in September, I stood in front of my open refrigerator, ravenous but unable to figure out what I should eat.

Continuous Glucose Monitoring Devices Market was valued at US$ 5.89 Bn in 2024 and is to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9%.

The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...

The new guidance includes updates on diabetes technology use, GLP-1 receptor agonists, liver disease, drinking water, and ...

It's not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock ...

The study will be published Dec. 6 in the journal Science. “The device’s design is analogous to a continuous glucose monitor that sits on your arm and measures levels right beneath your skin,” said ...

The S&P 500 Index has soared 28.6% in the same time frame. DXCM, a renowned medical device company and provider of continuous ...

Patients with type 1 diabetes were more likely to be prescribed continuous glucose monitoring compared with those with type 2 ...

In November, Cardinal Health announced its acquisition of Advanced Diabetes Supply Group (ADSG), a distributor of diabetic ...